News Home

Should Biotechnology Stock TRACON Pharmaceuticals Inc (TCON) Be in Your Portfolio Friday?

Friday, February 26, 2021 10:53 AM | InvestorsObserver Analysts
Should Biotechnology Stock TRACON Pharmaceuticals Inc (TCON) Be in Your Portfolio Friday?

A rating of 82 puts TRACON Pharmaceuticals Inc (TCON) near the top of the Biotechnology industry according to InvestorsObserver. TRACON Pharmaceuticals Inc's score of 82 means it scores higher than 82% of stocks in the industry. TRACON Pharmaceuticals Inc also received an overall rating of 63, putting it above 63% of all stocks. Biotechnology is ranked 33 out of the 148 industries.

Overall Score - 63
TCON has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on TCON!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With TRACON Pharmaceuticals Inc Stock Today?

TRACON Pharmaceuticals Inc (TCON) stock is trading at $8.47 as of 10:45 AM on Friday, Feb 26, a drop of -$0.53, or -5.94% from the previous closing price of $9.00. The stock has traded between $7.96 and $9.42 so far today. Volume today is light. So far 406,418 shares have traded compared to average volume of 548,653 shares.

Click Here to get the full Stock Score Report on TRACON Pharmaceuticals Inc (TCON) Stock.

You May Also Like